These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25639255)

  • 1. Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimen.
    Kimko H; Thyssen A; Mould DR; Mannaert E; Treem WR
    J Clin Pharmacol; 2015 May; 55(5):592-600. PubMed ID: 25639255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New dual therapy for primary treatment of Helicobacter pylori infection: A prospective randomized study in Shanghai, China.
    Ren L; Lu H; Li HY; Zhu LY; Xu XQ; Gu LY; Ge ZZ; Li XB
    J Dig Dis; 2014 Nov; 15(11):622-7. PubMed ID: 25205201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures.
    Goh KL; Manikam J; Qua CS
    Aliment Pharmacol Ther; 2012 May; 35(9):1097-102. PubMed ID: 22404486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
    Kawai T; Takahashi S; Suzuki H; Sasaki H; Nagahara A; Asaoka D; Matsuhisa T; Masaoaka T; Nishizawa T; Suzuki M; Ito M; Kurihara N; Omata F; Mizuno S; Torii A; Kawakami K; Ohkusa T; Tokunaga K; Mine T; Sakaki N
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():29-32. PubMed ID: 25521730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of rabeprazole and dosing recommendations for the treatment of gastroesophageal reflux disease in children aged 1-11 years.
    McLeay SC; Green B; Treem W; Thyssen A; Mannaert E; Kimko H
    Clin Pharmacokinet; 2014 Oct; 53(10):943-57. PubMed ID: 25168707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
    Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
    Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
    Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS
    J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection.
    Wu IC; Wu DC; Hsu PI; Lu CY; Yu FJ; Wang TE; Chang WH; Chen JJ; Kuo FC; Wu JY; Wang WM; Bair MJ
    Helicobacter; 2007 Dec; 12(6):633-7. PubMed ID: 18001406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study on Effect of Rabeprazole Versus Omeprazole in Acid-peptic Disorder with Helicobacter pylori Infection.
    Gurung SB; Kc SR; Gyawali P; Amatya GL
    J Nepal Health Res Counc; 2020 Jan; 17(4):479-484. PubMed ID: 32001852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens.
    Liu MK; Wu IC; Lu CY; Kuo CH; Yu FJ; Liu CJ; Hsu PI; Hsu WH; Su YC; Chen A; Wu DC; Kuo FC; Chen JJ
    Kaohsiung J Med Sci; 2013 Jul; 29(7):379-84. PubMed ID: 23768702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.
    Lee HJ; Kim JI; Cheung DY; Kim TH; Jun EJ; Oh JH; Chung WC; Kim BW; Kim SS; Park SH; Kim JK
    J Infect Dis; 2013 Oct; 208(7):1123-30. PubMed ID: 23801607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
    Mansour NM; Hashash JG; El-Halabi M; Ghaith O; Maasri K; Sukkarieh I; Malli A; Sharara AI
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):865-70. PubMed ID: 21811161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments.
    Sapmaz F; Kalkan IH; Güliter S; Atasoy P
    Eur J Intern Med; 2014 Mar; 25(3):224-9. PubMed ID: 24268371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.
    Choi HS; Park DI; Hwang SJ; Park JS; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    Helicobacter; 2007 Dec; 12(6):638-42. PubMed ID: 18001407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.